Japanese Encephalitis purified inactivated vaccine

BIOLOGICAL2 trials

Sponsors

Valneva Austria GmbH

Conditions

Japanese Encephalitis

Phase 3

Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51

CompletedNCT00595465

Valneva Austria GmbHJapanese Encephalitis

Start: 2007-12-31End: 2008-06-30Updated: 2014-05-16

Unknown Phase

Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51

CompletedNCT00596102

Valneva Austria GmbHJapanese Encephalitis

Start: 2005-10-31Updated: 2014-07-30

Related Papers

Persistence of the immune response after vaccination with the Japanese encephalitis vaccine, IXIARO® in healthy adults: A five year follow-up study

Vaccine2019-04-0516 citations